SEC Form 4 · accession 0001209191-15-087399
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry D Quart
Officer — Chief Executive Officer · Director
Period of report
Dec 28, 2015
Accepted (ET)
Dec 30, 2015 · 5:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 28, 2015 | M | 2,315 | $7.20 | A | 82,370 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $7.20 | Dec 28, 2015 | M | 2,315 | D | — | May 1, 2023 | Common Stock | 2,315 | 938,379 | D |
Explanation of responses
- F1At the date of filing, 178,976 shares of the options granted pursuant to the underlying awards are fully vested and exercisable.